<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Pharmacokinetics, biodistribution and antitumour activity of <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> (5-FU)-loaded <z:chebi fb="0" ids="53388">polyhydroxybutyrate</z:chebi> (<z:chebi fb="0" ids="53388">PHB</z:chebi>) and cellulose <z:chebi fb="49" ids="30089,47622">acetate</z:chebi> <z:chebi fb="0" ids="26092">phthalate</z:chebi> (CAP) blend microspheres were investigated in chemically induced <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in <z:mp ids='MP_0001189'>albino</z:mp> male Wistar rats and compared with pristine 5-FU given as a suspension </plain></SENT>
<SENT sid="1" pm="."><plain>The microspheres were characterised for particle size, encapsulation efficiency, in vitro release and in vitro cytotoxicity on human HT-29 <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell line </plain></SENT>
<SENT sid="2" pm="."><plain>Spherical particles with a mean size of 44 ± 11 µm were obtained that showed sustained release of 5-FU </plain></SENT>
<SENT sid="3" pm="."><plain>A high concentration of 5-FU was achieved in colonic tissues and significant reduction in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> volume and multiplicity were observed in animals treated with 5-FU-loaded microspheres </plain></SENT>
<SENT sid="4" pm="."><plain>The decreased levels of plasma albumin, <z:chebi fb="0" ids="16737">creatinine</z:chebi>, leucocytopenia and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> were observed in animals for 5-FU microspheres compared to the standard 5-FU formulation </plain></SENT>
<SENT sid="5" pm="."><plain>The results suggest the extended release of 5-FU from the <z:chebi fb="0" ids="53388">PHB</z:chebi>-CAP blend microspheres in colonic region to enhance the antitumour efficacy </plain></SENT>
</text></document>